260 related articles for article (PubMed ID: 34411353)
21. Subcutaneous phaeohyphomycosis caused by Exophiala equina, with susceptibility to eight antifungal drugs.
Najafzadeh MJ; Suh MK; Lee MH; Ha GY; Kim JR; Kim TH; Lee HJ; Choi JS; Meis JF; De Hoog GS
J Med Microbiol; 2013 May; 62(Pt 5):797-800. PubMed ID: 23449873
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
Lei HL; Li LH; Chen WS; Song WN; He Y; Hu FY; Chen XJ; Cai WP; Tang XP
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1099-1102. PubMed ID: 29536323
[TBL] [Abstract][Full Text] [Related]
23. Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
Ozdemir HG; Oz Y; Ilkit M; Kiraz N
Med Mycol; 2012 Feb; 50(2):130-5. PubMed ID: 21599550
[TBL] [Abstract][Full Text] [Related]
24. [Study of the susceptibility of black yeasts of the Exophiala genus to antifungals using the Sensititre System].
Puerto JL; García-Martos P; Marín P; Sepúlveda A; García-Agudo R; Aoufi S
Rev Esp Quimioter; 2002 Sep; 15(3):268-71. PubMed ID: 12582431
[TBL] [Abstract][Full Text] [Related]
25. Molecular typing and antifungal susceptibility of Exophiala isolates from patients with cystic fibrosis.
Packeu A; Lebecque P; Rodriguez-Villalobos H; Boeras A; Hendrickx M; Bouchara JP; Symoens F
J Med Microbiol; 2012 Sep; 61(Pt 9):1226-1233. PubMed ID: 22580912
[TBL] [Abstract][Full Text] [Related]
26. Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
Brito Devoto T; Hermida-Alva K; Posse G; Finquelievich JL; García-Effrón G; Cuestas ML
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37591630
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of eight antifungal drugs against Chaetomiaceae.
Dolatabadi S; Najafzadeh MJ; Houbraken J; Vicente V; de Hoog S; Meis JF
Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34791380
[TBL] [Abstract][Full Text] [Related]
28. Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Seneviratne CJ; Fong PH; Wong SS; Lee VH
BMC Oral Health; 2015 Mar; 15():39. PubMed ID: 25887752
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous Phaeohyphomycosis of the Right Hand Caused by Exophiala jeanselmei: A Case Report and Literature Review.
Wu C; Shu L; Chen Z; Hu Q; Tao L; He C
Mycopathologia; 2022 Jun; 187(2-3):259-269. PubMed ID: 35314920
[TBL] [Abstract][Full Text] [Related]
30. Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
Calvo E; Pastor FJ; Guarro J
J Antimicrob Chemother; 2010 Jul; 65(7):1455-9. PubMed ID: 20488983
[TBL] [Abstract][Full Text] [Related]
31. Phaeohyphomycosis caused by Exophiala spinifera: an increasing disease in young females in mainland China? Two case reports and review of five cases reported from mainland China.
Wang L; Wang C; Shen Y; Lv G; She X; Zeng R; Ping Z; Liu W
Mycoses; 2015 Mar; 58(3):193-6. PubMed ID: 25590223
[TBL] [Abstract][Full Text] [Related]
32. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
33. Consistent high prevalence of Exophiala dermatitidis, a neurotropic opportunist, on railway sleepers.
Yazdanparast SA; Mohseni S; De Hoog GS; Aslani N; Sadeh A; Badali H
J Mycol Med; 2017 Jun; 27(2):180-187. PubMed ID: 28190754
[TBL] [Abstract][Full Text] [Related]
34. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Deng S; de Hoog GS; Badali H; Yang L; Najafzadeh MJ; Pan B; Curfs-Breuker I; Meis JF; Liao W
Antimicrob Agents Chemother; 2013 Apr; 57(4):1974-7. PubMed ID: 23380718
[TBL] [Abstract][Full Text] [Related]
35. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
[TBL] [Abstract][Full Text] [Related]
36. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review.
Zhu X; Ma J; Zheng B; Cai W; Li J; Lin L; Xi L; Li X; Lu S
Mycoses; 2023 Nov; 66(11):1012-1017. PubMed ID: 37553547
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
[TBL] [Abstract][Full Text] [Related]
39. Spectrum of clinically relevant Exophiala species in the United States.
Zeng JS; Sutton DA; Fothergill AW; Rinaldi MG; Harrak MJ; de Hoog GS
J Clin Microbiol; 2007 Nov; 45(11):3713-20. PubMed ID: 17596364
[TBL] [Abstract][Full Text] [Related]
40. Rapid Identification of Clinically Relevant Members of the Genus Exophiala by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Description of Two Novel Species, Exophiala campbellii and Exophiala lavatrina.
Borman AM; Fraser M; Szekely A; Larcombe DE; Johnson EM
J Clin Microbiol; 2017 Apr; 55(4):1162-1176. PubMed ID: 28122875
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
